This announcement is a separate document:
四環醫藥：自願公告 - 惠升生物研發的德谷胰島素利拉魯肽注射液臨床試驗申請獲國家藥監局批准
SIHUAN PHARM: VOLUNTARY ANNOUNCEMENT - IND APPLICATION OF INSULIN DEGLUDEC AND LIRAGLUTIDE INJECTION, DEVELOPED BY HUISHENG BIOPHARMACEUTICAL, APPROVED BY NMPA
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.